Alps Advisors Inc Alkermes Plc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Alps Advisors Inc holds 126,222 shares of ALKS stock, worth $3.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

126,222

Previous 131,992 4.37%

Holding current value

$3.74 Million

Previous $3.18 Million 11.03%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.01 - $28.55 $132,767 - $164,733	-5,770 Reduced 4.37%	126,222 $3.53 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $328,328 - $385,337	14,146 Added 12.0%	131,992 $3.18 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $24,921 - $30,736	944 Added 0.81%	117,846 $3.19 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $140,547 - $172,481	-6,014 Reduced 4.89%	116,902 $3.24 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $14,372 - $16,912	529 Added 0.43%	122,916 $3.44 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $398,970 - $473,443	14,078 Added 13.0%	122,387 $3.83 Million
Q1 2023 May 10, 2023	SELL	$25.31 - $29.02 $76,790 - $88,046	-3,034 Reduced 2.72%	108,309 $3.05 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $474,803 - $567,859	21,641 Added 24.13%	111,343 $2.91 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $173,580 - $251,454	-7,890 Reduced 8.08%	89,702 $2 Million
Q2 2022 Aug 11, 2022	SELL	$26.4 - $30.54 $1.83 Million - $2.12 Million	-69,267 Reduced 41.51%	97,592 $2.91 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $478,171 - $580,148	-20,727 Reduced 11.05%	166,859 $4.39 Million
Q4 2021 Feb 09, 2022	SELL	$21.47 - $32.08 $228,011 - $340,689	-10,620 Reduced 5.36%	187,586 $4.36 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $285,838 - $392,982	-12,231 Reduced 5.81%	198,206 $6.11 Million
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $1.46 Million - $1.95 Million	-77,501 Reduced 26.92%	210,437 $5.16 Million
Q1 2021 May 07, 2021	BUY	$18.21 - $23.2 $8,467 - $10,788	465 Added 0.16%	287,938 $5.38 Million
Q4 2020 Feb 03, 2021	BUY	$15.39 - $22.1 $4.42 Million - $6.35 Million	287,473 New	287,473 $5.74 Million
Q3 2020 Nov 04, 2020	SELL	$16.16 - $20.66 $3.5 Million - $4.47 Million	-216,536 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$13.31 - $19.41 $918,576 - $1.34 Million	-69,014 Reduced 24.17%	216,536 $4.2 Million
Q1 2020 May 06, 2020	SELL	$13.06 - $21.24 $411,755 - $669,654	-31,528 Reduced 9.94%	285,550 $4.12 Million
Q4 2019 Feb 07, 2020	BUY	$17.29 - $21.74 $65,615 - $82,503	3,795 Added 1.21%	317,078 $6.47 Million
Q3 2019 Nov 04, 2019	SELL	$19.51 - $24.28 $272,983 - $339,725	-13,992 Reduced 4.28%	313,283 $6.11 Million
Q2 2019 Aug 07, 2019	BUY	$21.47 - $37.33 $7.03 Million - $12.2 Million	327,275 New	327,275 $7.38 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Alkermes Plc. Transaction History